BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, August 1, 2026
Home » Authors » Sergio Held

Sergio Held

Articles

ARTICLES

Venezuelan med-tech guild confronts non-responsive government

Feb. 25, 2016
By Sergio Held

Embattled Sientra gets ready to go back to work after certification debacle

Feb. 16, 2016
By Sergio Held
BOGOTA, Colombia — After facing an unprecedented crisis last year, breast implants company Sientra Inc. reported that it is ready to resume its commercial activities next month.
Read More

Looking to Replace traditional syringes :Mexican millennials developing futuristic med-tech products

Feb. 5, 2016
By Sergio Held

Steba enters LatAm, files MAA in Europe for prostate cancer drug

Jan. 28, 2016
By Sergio Held

Steba enters LatAm, files MAA in Europe for prostate cancer drug

Jan. 28, 2016
By Sergio Held
BOGOTA, Colombia – After 12 years in relative stealth mode, Steba Biotech, a Luxembourg-based company owned by Israeli shareholders is launching operations in Latin America and submitted a marketing authorization application (MAA) to the EMA for Tookad, seeking approval to market the drug for the treatment of localized prostate cancer.
Read More

Silimed issues still not resolved: Sientra's new CEO updates physicians over crisis with Brazilian operations

Jan. 13, 2016
By Sergio Held

HPV vaccine under fire in Brazil; MFP files action requesting ban

Jan. 8, 2016
By Sergio Held
BOGOTA, Colombia – Multinational manufacturers of human papillomavirus (HPV) vaccines are getting ready to defend the effectiveness of the product in Brazil after a public attorney set out to ban them across the country.
Read More

Eurofarma looking for opportunities to expand into Africa, Asia, U.S.

Dec. 30, 2015
By Sergio Held
BOGOTA, Colombia – Brazilian pharma major Eurofarma is looking to expand its footprint by tapping into markets in Africa, investing in the U.S. and reaching deeper into Latin America markets through new plants, the acquisition of established businesses and by introducing new products.
Read More

Tijuana's med-tech sector enjoyed much success in 2015

Dec. 29, 2015
By Sergio Held

Prostate diagnosis kits: Mdxhealth enters LatAm market with Uruguayan partner Southgenetics

Dec. 22, 2015
By Sergio Held
View All Articles by Sergio Held

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 31, 2026.
  • Illustration of dopamine signaling in the brain

    New schizophrenia targets challenge trial design

    BioWorld
    The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 28, 2026
  • HIV virus

    AIDS 2026: New targets for metabolic dysfunction despite ART

    BioWorld
    Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
  • Lee-Cheng Liu, chairman, Taiwan BIO

    Taiwan biotech looks outward in next phase of growth

    BioWorld
    Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing